Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Incorporating stereotactic body radiation therapy for inoperable pancreatic cancer.
Authors
Alexander Lukez
Fox Chase Cancer Center, Philadelphia, PA
Alexander Lukez , Jill S. Hasler , Sanjay S. Reddy , Efrat Dotan , Igor A. Astsaturov , Shannon M. Lynch , Kristen A. Sorice , Joshua E. Meyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 656)
DOI
10.1200/JCO.2024.42.3_suppl.656
Abstract #
656
Poster Bd #
L5
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
A phase 2 study of cyclophosphamide (CY), GVAX, pembrolizumab (Pembro), and stereotactic body radiation (SBRT) in patients (pts) with locally advanced pancreas cancer (LAPC).
First Author: Valerie Lee
Poster
2024 ASCO Annual Meeting
Phase 1 study to evaluate safety and preliminary efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in patients with locally advanced (LA) unresectable pancreatic ductal adenocarcinoma (PDAC).
First Author: Nadine Abi-Jaoudeh
Poster
2024 ASCO Annual Meeting
Primary prophylaxis with pegylated-granulocyte colony-stimulating factor for patients with unresectable pancreatic cancer treated with modified-FOLFIRINOX: A randomized phase II trial.
First Author: Choong-kun Lee
Poster
2024 ASCO Gastrointestinal Cancers Symposium
SBRT with ipilimumab and nivolumab to metastatic MSS colorectal and pancreatic cancer: A pooled analysis of four prospective phase II trials.
First Author: Hannah Johnson Roberts